Moneycontrol PRO
HomeNewsGlaxosmithkline pharmaceuticals

Glaxosmithkline Pharmaceuticals

Jump to
  • GlaxoSmithKline Consolidated June 2025 Net Sales at Rs 805.17 crore, down 1.16% Y-o-Y

    GlaxoSmithKline Consolidated June 2025 Net Sales at Rs 805.17 crore, down 1.16% Y-o-Y

  • GlaxoSmithKline Standalone June 2025 Net Sales at Rs 804.83 crore, down 0.76% Y-o-Y

    GlaxoSmithKline Standalone June 2025 Net Sales at Rs 804.83 crore, down 0.76% Y-o-Y

  • Chartist Talks: Bank Nifty on track to hit 60,000 milestone before Diwali, bullish on these 4 stocks, says SBI Securities' Sudeep Shah

    Chartist Talks: Bank Nifty on track to hit 60,000 milestone before Diwali, bullish on these 4 stocks, says SBI Securities' Sudeep Shah

    Backed by strong technical indicators and firm sectoral participation, Nifty now looks poised to extend its northward journey in the coming weeks and is likely to test the level of 25,800, followed by 26,100 in the short term, said SBI Securities' Sudeep Shah.

  • Trade Spotlight: How should you trade CDSL, Manappuram Finance, Wockhardt, HDFC Life Insurance, GSK Pharma and others on June 2?

    Trade Spotlight: How should you trade CDSL, Manappuram Finance, Wockhardt, HDFC Life Insurance, GSK Pharma and others on June 2?

    The market is expected to trade with a positive bias, albeit within a likely rangebound zone. Below are some short-term trading ideas to consider.

  • Stocks to Watch Today: Divis Labs, Premier Energies, Delhivery, Dr Reddys, Bharat Electronics, KEC International, Sun Pharma, PNC Infratech in focus on 19 May

    Stocks to Watch Today: Divis Labs, Premier Energies, Delhivery, Dr Reddys, Bharat Electronics, KEC International, Sun Pharma, PNC Infratech in focus on 19 May

    Stocks to Watch, 19 May: Stocks like Zen Technologies, Arvind Fashions, Galaxy Surfactants, KRBL, Kalpataru Projects International, IOL Chemicals, Repco Home Finance, CreditAccess Grameen, Dhampur Sugar Mills, Gujarat Alkalies, Kaynes Technology India, Texmaco Rail & Engineering, Sterlite Technologies, and Dr Reddy's Laboratories will be in focus on May 19.

  • Reduce GlaxoSmithKline Pharmaceuticals: target of Rs 2,600: ICICI Securities

    Reduce GlaxoSmithKline Pharmaceuticals: target of Rs 2,600: ICICI Securities

    ICICI Securities recommended reduce rating on GlaxoSmithKline Pharmaceuticals with a target price of Rs 2,600 in its research report dated May 14, 2025.

  • Stocks to Watch Today: Bharti Airtel, Tata Motors, Dalmia Bharat Sugar, Metropolis, ITD Cementation, ASK Automotive, Bharti Hexacom in focus on 14 May

    Stocks to Watch Today: Bharti Airtel, Tata Motors, Dalmia Bharat Sugar, Metropolis, ITD Cementation, ASK Automotive, Bharti Hexacom in focus on 14 May

    Stocks to watch, 14 May: Stocks like AurionPro Solutions,VST Tillers Tractors,VIP Industries,Honeywell Automation,GlaxoSmithKline Pharmaceuticals, Metropolis Healthcare, ITD Cementation India, Max Financial Services, Garden Reach Shipbuilders & Engineers, ASK Automotive, Bharti Airtel,Tata Motors,Dalmia Bharat Sugar and Industries, and Bharti Hexacom will be in focus on May 14.

  • GlaxoSmithKline Standalone March 2025 Net Sales at Rs 966.08 crore, up 6.06% Y-o-Y

    GlaxoSmithKline Standalone March 2025 Net Sales at Rs 966.08 crore, up 6.06% Y-o-Y

  • GlaxoSmithKline Consolidated March 2025 Net Sales at Rs 974.37 crore, up 4.79% Y-o-Y

    GlaxoSmithKline Consolidated March 2025 Net Sales at Rs 974.37 crore, up 4.79% Y-o-Y

  • Trade Spotlight: How should you trade Steel Strips Wheels, Honasa Consumer, Bharat Electronics, UPL, GSK Pharma, and others on May 5?

    Trade Spotlight: How should you trade Steel Strips Wheels, Honasa Consumer, Bharat Electronics, UPL, GSK Pharma, and others on May 5?

    Benchmark indices may once again attempt to test the previous day's highs, but sustaining those levels is the key to watch amid ongoing consolidation. Below are some short-term trading ideas to consider.

  • Stocks to Watch Today: Bajaj Finance, IndusInd Bank, IndiaMART, Schaeffler India, Vishal Mega Mart, Prestige Estates, Strides Pharma in focus on 30 April

    Stocks to Watch Today: Bajaj Finance, IndusInd Bank, IndiaMART, Schaeffler India, Vishal Mega Mart, Prestige Estates, Strides Pharma in focus on 30 April

    Stocks to watch, 30 Apr: Stocks like Bajaj Finserv, Bharat Petroleum Corporation, Jana Small Finance Bank, UTI Asset Management Company, Star Health, Ceat, Shoppers Stop, CIE Automotive India, Praj Industries, Indostar Capital Finance, Fedbank Financial Services, and State Bank of India will be in focus on April 30.

  • Market turning around? 3 stock picks backed by multi-timeframe analysis

    Market turning around? 3 stock picks backed by multi-timeframe analysis

    Rather than solely betting on a bounce or trend reversal in the broader index, look to stocks like Castrol India, Cholamandalam Investment, and GlaxoSmithKline that demonstrate potential bullish signals across multiple timeframes.

  • GlaxoSmithKline Consolidated December 2024 Net Sales at Rs 949.42 crore, up 17.9% Y-o-Y

    GlaxoSmithKline Consolidated December 2024 Net Sales at Rs 949.42 crore, up 17.9% Y-o-Y

  • GlaxoSmithKline Consolidated September 2024 Net Sales at Rs 1,010.77 crore, up 5.62% Y-o-Y

    GlaxoSmithKline Consolidated September 2024 Net Sales at Rs 1,010.77 crore, up 5.62% Y-o-Y

  • GlaxoSmithKline Standalone September 2024 Net Sales at Rs 1,000.05 crore, up 4.9% Y-o-Y

    GlaxoSmithKline Standalone September 2024 Net Sales at Rs 1,000.05 crore, up 4.9% Y-o-Y

  • Stock Radar: Voltas, Marico, Torrent Pharma, Godavari Biorefineries, Sar Televenture, Kaynes Tech, Hitachi Energy in focus on Wednesday

    Stock Radar: Voltas, Marico, Torrent Pharma, Godavari Biorefineries, Sar Televenture, Kaynes Tech, Hitachi Energy in focus on Wednesday

    Stocks like Glaxosmithkline Pharmaceuticals, Container Corporation, Prestige Estates Projects, Capri Global Capital, Redington, Motisons Jewellers, Honeywell Automation, MTAR Technologies, and Welspun Enterprises will also be in focus on October 30.

  • GlaxoSmithKline Pharmaceuticals Q2 net profit rises 16% to Rs 252 crore

    GlaxoSmithKline Pharmaceuticals Q2 net profit rises 16% to Rs 252 crore

    The company's board declared a special interim dividend of Rs 12 per equity share of face value of Rs 10 each

  • Stock Radar: AU SFB, GIC, GSK Pharma, Godfrey Phillips, Exicom, Ecos India Mobility in focus on Wednesday

    Stock Radar: AU SFB, GIC, GSK Pharma, Godfrey Phillips, Exicom, Ecos India Mobility in focus on Wednesday

    Stocks like Mankind Pharma, Indian Energy Exchange, NHPC, BGR Energy Systems, PDS, Jindal Stainless, and Medi Assist Healthcare Services will also be in focus on September 4.

  • Hold GlaxoSmithKline Pharmaceuticals: target of Rs 2640: ICICI Securities

    Hold GlaxoSmithKline Pharmaceuticals: target of Rs 2640: ICICI Securities

    ICICI Securities recommended hold rating on GlaxoSmithKline Pharmaceuticals with a target price of Rs 2640 in its research report dated August 05, 2024.

  • GlaxoSmithKline Consolidated June 2024 Net Sales at Rs 814.65 crore, up 6.96% Y-o-Y

    GlaxoSmithKline Consolidated June 2024 Net Sales at Rs 814.65 crore, up 6.96% Y-o-Y

  • GlaxoSmithKline Standalone June 2024 Net Sales at Rs 811.00 crore, up 9.89% Y-o-Y

    GlaxoSmithKline Standalone June 2024 Net Sales at Rs 811.00 crore, up 9.89% Y-o-Y

  • Stock Radar: CE Info Systems, Sanghi Industries, NTPC, DEE Development in focus on Wednesday

    Stock Radar: CE Info Systems, Sanghi Industries, NTPC, DEE Development in focus on Wednesday

    UltraTech Cement, Mahindra & Mahindra Financial Services, RattanIndia Enterprises, Adani Ports and Special Economic Zone, SMC Global Securities, GlaxoSmithKline Pharmaceuticals, and Zee Entertainment will also be in focus on Wednesday.

  • GlaxoSmithKline Consolidated March 2024 Net Sales at Rs 929.80 crore, up 18.08% Y-o-Y

    GlaxoSmithKline Consolidated March 2024 Net Sales at Rs 929.80 crore, up 18.08% Y-o-Y

  • GlaxoSmithKline Standalone March 2024 Net Sales at Rs 910.87 crore, up 16.46% Y-o-Y

    GlaxoSmithKline Standalone March 2024 Net Sales at Rs 910.87 crore, up 16.46% Y-o-Y

  • GlaxoSmithKline Consolidated December 2023 Net Sales at Rs 805.26 crore, up 0.37% Y-o-Y

    GlaxoSmithKline Consolidated December 2023 Net Sales at Rs 805.26 crore, up 0.37% Y-o-Y

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347